How does the accordquick system achieve integrated operation of nucleic acid extraction and detection?
Publish Time: 2025-07-22
At the forefront of modern medical technology, the accordquick system is quietly rewriting the future of nucleic acid detection with an efficient, intelligent and precise attitude. It no longer requires complex laboratory operation procedures, nor does it rely on complicated manual intervention. Instead, it integrates nucleic acid extraction, amplification, detection and analysis in one, like a "smart brain in a biological laboratory", completing the accurate identification of pathogens and gene targets in a small space. It is not only a fusion of technology and medicine, but also a new interpretation of the "fast, accurate and convenient" detection concept.
The core of the fully automatic thin film microfluidic nucleic acid detection all-in-one machine lies in its innovative thin film microfluidic technology and fluorescent quantitative PCR technology. Through the microfluidic chip, the sample processing, reaction, amplification and other processes are completed in a closed and miniaturized system, avoiding the cumbersome step-by-step operation and possible cross-contamination in traditional detection. The introduction of fluorescent quantitative PCR technology ensures high sensitivity and high specificity of the detection. Even extremely small amounts of viruses or gene fragments can be accurately identified, truly achieving "seeing the big from the small".
Interestingly, although the accordquick system performs high-precision molecular biology experiments, its operation is extremely simple. Users only need to put the sample into the device and select the test items, and the system will automatically complete all subsequent processes, from nucleic acid extraction to result analysis, without human intervention. This "one-click" operation makes it easy for even non-professionals to get started, greatly reducing the threshold for testing, so that nucleic acid testing is no longer exclusive to laboratories, but can be brought into community hospitals, disease control centers, airport ports, and even the front lines in remote areas.
From the appearance point of view, the accordquick system also shows a "technological beauty" unique to modern medical equipment. The body has smooth lines, a modular design, a compact structure, and is easy to move and deploy. The operation interface is simple and intuitive, equipped with a large-size touch screen, which displays the progress and results of the test in real time. Some models also support wireless data transmission, and the test results can be directly uploaded to the cloud or hospital information system to achieve remote diagnosis and data sharing, truly achieving "visible, usable, and connected".
More importantly, the accordquick system has an extremely wide range of applications. It can not only be used to detect respiratory viruses (such as COVID-19, influenza, adenovirus, etc.), but also be applied to genetic disease screening, tumor gene detection, drug-resistant gene analysis and other fields. This multi-purpose, multi-scenario adaptability allows it to show great potential in public health, clinical diagnosis, scientific research institutions and emergency response.
It can be said that the accordquick system is not just a member of the nucleic acid detection equipment, it is a model of the combination of modern medical technology and intelligent manufacturing, and an important force in promoting the development of precision medicine and smart medicine. It uses tiny chips to tell the grand story of life, uses automated processes to interpret the future of medicine, and silently injects a speed and accuracy into every test.
